Lipophilicity in drug design: an overview of lipophilicity descriptors in 3D-QSAR studies
| dc.contributor.author | Ginex, Tiziana | |
| dc.contributor.author | Vázquez, Javier | |
| dc.contributor.author | Gibert, Enric | |
| dc.contributor.author | Herrero, Enric | |
| dc.contributor.author | Luque Garriga, F. Xavier | |
| dc.date.accessioned | 2020-06-16T06:49:25Z | |
| dc.date.available | 2020-06-16T06:49:25Z | |
| dc.date.issued | 2019-02-25 | |
| dc.date.updated | 2020-06-16T06:49:26Z | |
| dc.description.abstract | The pharmacophore concept is a fundamental cornerstone in drug discovery, playing a critical role in determining the success of in silico techniques, such as virtual screening and 3D-QSAR studies. The reliability of these approaches is influenced by the quality of the physicochemical descriptors used to characterize the chemical entities. In this context, a pivotal role is exerted by lipophilicity, which is a major contribution to host-guest interaction and ligand binding affinity. Several approaches have been undertaken to account for the descriptive and predictive capabilities of lipophilicity in 3D-QSAR modeling. Recent efforts encode the use of quantum mechanical-based descriptors derived from continuum solvation models, which open novel avenues for gaining insight into structure-activity relationships studies. | |
| dc.format.extent | 17 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 687404 | |
| dc.identifier.issn | 1756-8919 | |
| dc.identifier.uri | https://hdl.handle.net/2445/165738 | |
| dc.language.iso | eng | |
| dc.publisher | Future Science | |
| dc.relation.isformatof | Versió postprint del document publicat a: https://doi.org/10.4155/fmc-2018-0435 | |
| dc.relation.ispartof | Future Medicinal Chemistry, 2019, vol. 11, num. 10, p. 1177-1193 | |
| dc.relation.uri | https://doi.org/10.4155/fmc-2018-0435 | |
| dc.rights | (c) Future Science, 2019 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.source | Articles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia) | |
| dc.subject.classification | Lipofília | |
| dc.subject.classification | Solvatació | |
| dc.subject.classification | Disseny de medicaments | |
| dc.subject.classification | Lligands (Bioquímica) | |
| dc.subject.classification | Relacions estructura-activitat (Bioquímica) | |
| dc.subject.other | Lipophilicity | |
| dc.subject.other | Solvation | |
| dc.subject.other | Drug design | |
| dc.subject.other | Ligands (Biochemistry) | |
| dc.subject.other | Structure-activity relationships (Biochemistry) | |
| dc.title | Lipophilicity in drug design: an overview of lipophilicity descriptors in 3D-QSAR studies | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/acceptedVersion |
Fitxers
Paquet original
1 - 1 de 1